Andrew Kuykendall, MD
Associate Member, Department of Malignant Hematology — Moffitt Cancer Center
Dr. Kuykendall is a hematologist-oncologist specializing in myelofibrosis, myeloproliferative neoplasms (MPNs), MDS/MPN overlap syndromes, and systemic mastocytosis. He earned his MD from the University of Florida College of Medicine and completed internal medicine residency and hematology/medical oncology fellowship at the University of South Florida/Moffitt Cancer Center. His research focuses on disease progression, molecular biomarkers, and disease-modifying therapies for myeloid malignancies. He has authored numerous publications in Blood, Leukemia, Cancer, Nature Medicine, and other peer-reviewed journals and serves as principal investigator on clinical trials.
Areas of Focus: Myelofibrosis, MPNs, MDS/MPN Overlap Syndromes, Systemic Mastocytosis, Myeloid Malignancies, Clinical Trials
Latest Content
PV at ASH 2025
01/08/2026
Ep. 3: Managing Hematocrit and Symptoms in PV: Dose-Titration Strategies for Rusfertide
PV at ASH 2025
01/06/2026
Ep. 2: Integrating Rusfertide Into the Polycythemia Vera Treatment Algorithm
PV at ASH 2025
01/02/2026
Ep. 1: Clinical Insights: New Approaches to Hematocrit Control in Polycythemia Vera
PV at ASH 2025
12/22/2025